Health Condition 1: I708- Atherosclerosis of other arteries
Conditions
Interventions
Intervention1: Nutraceutical-vitamin: 2 tablets per day for 6 months
Intervention2: L arginine sachet: 2 tablets per day for 2 months
Intervention3: nutraceutical: 1 tablet per day for 2 months
Interv
Sponsors
Bhaktivedanta Hospital and Research Institute
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with age criteria of 30 years and above. 2. All genders will be included in the study. 3. NYHA (New York Heart Association) Class-II 4. Chronic Stable Angina 5. Patients who are advised for CT angiography and with coronary artery and aortic CT scoring (combined score) of greater than or equal to 10 and stenosis of score between 40-70 will be included in the study.
Exclusion criteria
Exclusion criteria: 1. Unstable/Severe Angina 2. Symptomatic patients 3. Already experienced events such as ACS, MI 4. Heart failure with ejection fraction 5. Estimated glomerular filtration rate 6. White blood cell count 7. History of actual alcohol abuse or unwillingness to limit alcohol consumption to 8. Chronic use of oral steroid therapy or other immunosuppressive or biologic response modifiers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate impact of integrated-SHARP veda therapy on coronary artery plaques’ stability, morphology and progression.Timepoint: The timepoints are 0, 3 and 6 months respectively. | — |
Secondary
| Measure | Time frame |
|---|---|
| •To evaluate the impact of integrated-SHARP veda therapy on coronary arteries calcification based on calcium scoring. •To evaluate the impact of integrated-SHARP veda therapy on quality of life. •To evaluate clinical events occurring during the study period.Timepoint: The timepoints are 0, 3 and 6 months respectively. | — |
Countries
India
Contacts
Public ContactDr Dhaval Dalal
Bhaktivedanta Hospital and Research Institute
Outcome results
None listed